Scott E. Lazerwith
Impact in
- Virology top 2%
- HIV Research and Treatment
- Pharmacology top 2%
- Cannabis and Cannabinoid Research
Papers in
-
- Hepatitis C virus research 8
- Virology 6
- HIV Research and Treatment 6
- Co-authors
- Marya B. Liimatta (3 shared papers)Douglas S. Johnson (3 shared papers)Cory M. Stiff (3 shared papers)Kay Ahn (3 shared papers)Benjamin F. Cravatt (3 shared papers)David R. Beidler (3 shared papers)Sarah E. Smith (3 shared papers)Elias James Corey (2 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (5 papers)Journal of the American Chemical Society (3 papers)Journal of Medicinal Chemistry (3 papers)ACS Medicinal Chemistry Letters (2 papers)Journal of Hepatology (2 papers)
- Partner nations
- United StatesHong KongCanada
In The Last Decade
Scott E. Lazerwith
22 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 86
- Virology 321
- Pharmacology 477
- Infectious Diseases 496
- Toxicology 80
- Hepatology 102
Countries citing papers authored by Scott E. Lazerwith
This map shows the geographic impact of Scott E. Lazerwith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott E. Lazerwith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott E. Lazerwith more than expected).
Fields of papers citing papers by Scott E. Lazerwith
This network shows the impact of papers produced by Scott E. Lazerwith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott E. Lazerwith. The network helps show where Scott E. Lazerwith may publish in the future.
Co-authors
The 25 scholars most cited alongside Scott E. Lazerwith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 389 | |
| 2 | 2020 | 322 | |
| 3 | 2016 | 248 | |
| 4 | 2010 | 165 | |
| 5 | 2005 | 85 | |
| 6 | 2009 | 60 | |
| 7 | 1998 | 58 | |
| 8 | 1997 | 49 | |
| 9 | 2000 | 46 | |
| 10 | 2012 | 36 | |
| 11 | 2013 | 31 | |
| 12 | 2021 | 27 | |
| 13 | 2013 | 21 | |
| 14 | 2011 | 17 | |
| 15 | 2022 | 15 | |
| 16 | 2022 | 13 | |
| 17 | 2019 | 13 | |
| 18 | 2024 | 5 | |
| 19 | 2022 | 3 | |
| 20 | 2025 | 2 |
About Scott E. Lazerwith
Scott E. Lazerwith is a scholar working on Hepatology, Virology, Infectious Diseases, Epidemiology and Pharmacology, having authored 22 papers that have together received 1.6k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (9 papers), Hepatitis C virus research (8 papers), HIV Research and Treatment (6 papers), Hepatitis B Virus Studies (6 papers), Biochemical and Molecular Research (4 papers), Liver Disease Diagnosis and Treatment (4 papers), Cannabis and Cannabinoid Research (3 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Virology (321 citations), Pharmacology (477 citations), Infectious Diseases (496 citations), Toxicology (80 citations) and Hepatology (102 citations). Scott E. Lazerwith has collaborated with scholars based in United States, Hong Kong and Canada. Frequent co-authors include Marya B. Liimatta, Douglas S. Johnson, Cory M. Stiff, Kay Ahn, Benjamin F. Cravatt, David R. Beidler, Sarah E. Smith, Elias James Corey, Nalini Sadagopan and E.J. Corey. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of the American Chemical Society, Journal of Medicinal Chemistry, ACS Medicinal Chemistry Letters and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.